Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00611_DB06274_nanopub.RApECbULUu2tLuwsXeyT4sv0YgBZ26zP7nKwgLZPB6i50#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00611_DB06274 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00611_DB06274 label "DDI between Butorphanol and Alvimopan - Opioid analgesics such as butorphanol may enhance the adverse/toxic effect of alvimopan. This is most notable for patients receiving long-term (i.e., more than 7 days) opiates prior to alvimopan initiation. According to alvimopan prescribing information, alvimopan is contraindicated in patients receiving therapeutic doses of opioids for more than 7 consecutive days immediately prior to alvimopan initiation. Monitor for increased alvimopan adverse effects in patients using opioids prior to alvimopan. [drugbank_resource:DB00611_DB06274]" assertion.
- drugbank_resource:DB00611_DB06274 identifier "drugbank_resource:DB00611_DB06274" assertion.
- drugbank_resource:DB00611_DB06274 title "DDI between Butorphanol and Alvimopan - Opioid analgesics such as butorphanol may enhance the adverse/toxic effect of alvimopan. This is most notable for patients receiving long-term (i.e., more than 7 days) opiates prior to alvimopan initiation. According to alvimopan prescribing information, alvimopan is contraindicated in patients receiving therapeutic doses of opioids for more than 7 consecutive days immediately prior to alvimopan initiation. Monitor for increased alvimopan adverse effects in patients using opioids prior to alvimopan." assertion.
- drugbank:DB06274 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00611_DB06274 assertion.
- drugbank:DB00611 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00611_DB06274 assertion.